Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 5000.00 | 1699.69 | 5991.00 | 5812.25 | 1.0308 | 1.0344 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5997.00 | 5812.25 | 1.0318 | 1.0356 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 1.00 | 5812.25 | 0.0002 | -0.9849 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 3.00 | 5812.25 | 0.0005 | -0.9720 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5815.00 | 5812.25 | 1.0005 | 1.0005 | |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 4863.00 | 5812.25 | 0.8367 | 0.8087 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5742.00 | 5812.25 | 0.9879 | 0.9863 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 5000.00 | 1699.69 | 3538.00 | 5812.25 | 0.6087 | 0.5118 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 5000.00 | 1699.69 | 5647.00 | 5812.25 | 0.9716 | 0.9677 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 5000.00 | 1699.69 | 3177.00 | 5812.25 | 0.5466 | 0.4228 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 5000.00 | 1699.69 | 5910.00 | 5812.25 | 1.0168 | 1.0189 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 4077.00 | 5812.25 | 0.7015 | 0.6376 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5734.00 | 5812.25 | 0.9865 | 0.9848 | |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 3901.00 | 5812.25 | 0.6712 | 0.5974 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5449.00 | 5812.25 | 0.9375 | 0.9285 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5808.00 | 5812.25 | 0.9993 | 0.9992 | |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 5000.00 | 1699.69 | 3629.00 | 5812.25 | 0.6244 | 0.5336 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5904.00 | 5812.25 | 1.0158 | 1.0177 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 5000.00 | 1699.69 | 3636.00 | 5812.25 | 0.6256 | 0.5353 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 5000.00 | 1699.69 | 4433.00 | 5812.25 | 0.7627 | 0.7168 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 5853.00 | 5812.25 | 1.0070 | 1.0079 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 6095.00 | 5812.25 | 1.0486 | 1.0543 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 5000.00 | 1699.69 | 3725.00 | 5812.25 | 0.6409 | 0.5563 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 5000.00 | 1699.69 | 3468.00 | 5812.25 | 0.5967 | 0.4949 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5471.00 | 5812.25 | 0.9413 | 0.9329 |